SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?


To: limit who wrote (834)12/17/1998 9:23:00 PM
From: tom jones  Respond to of 998
 
To all: Modafinil is a Laboratoire L. Lafon product and they sell it in France. Cephalon has the rights to Modafinil in the UK, US, Ireland, Japan, Italy, Mexico and the right to promote it in Austria and Switzerland.
What does promote mean in terms of money?
Does anyone know what kind of sales there are in France or the UK?
Who is making the drug?
What kind of profit margin can Cephalon make on sales of this drug.
Comments please.
Tom



To: limit who wrote (834)12/21/1998 2:40:00 PM
From: tom jones  Read Replies (1) | Respond to of 998
 
To all: Looks like Orphan Medical will sell a drug for narcolepsy while it is in trials for approval.
biz.yahoo.com
Tom